Bracket, a clinical trial technology and specialty services provider, announced the release of CUBETM, a transformative interactive response technology (IRT) solution for the life sciences industry.
The solution leverages an iterative user acceptance build experience, which allows a UAT process that study teams can visualize during the kick off meeting. Features include:
Accelerate times for sponsors and improves efficiency for CROs
Leverages Bracket's RTSM platform, but streamlines deployment through automation
Rapid project lifecycle lets sponsors experience the system prior to requirements approval
Reduce lengthy turnaround times for enhancements and in-study changes
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.